Skip to main content
SpringerLink
Log in

Combination Therapy for Prevention of Atrial Fibrillation after Coronary Artery Bypass Surgery: A Randomized Trial of Sotalol and Magnesium

  • Published:
Cardiac Electrophysiology Review

Abstract

Objective: Atrial Fibrillation (AF) is a common complication of coronary artery bypass surgery reported to occur in 20–40% of patients. Sotalol alone and magnesium alone have been shown to decrease the incidence of AF. The aim of this study was to evaluate the efficacy of these two agents, alone or in combination, to reduce postoperative AF.

Methods: Two hundreds and seven consecutive coronary artery bypass patients were randomized to receive sotalol alone (80 mg two times daily for five days starting from the morning of the first postoperative day), magnesium alone (1.5 g daily for six days starting in the operating room just before cardiopulmonary bypass), both pharmacological agents at the same dosages or no antiarrhythmic agents (Control group). Patients with an ejection fraction <40% were excluded.

Results: The incidence of postoperative AF was 11.8% (6/51) in the sotalol group, 14.8% (8/54) in the magnesium group, 1.9% (1/52) in sotalol+magnesium group and 38% (19/50) in the control group. The differences were significant between the control group and the other three groups (sotalol, magnesium and sotalol + magnesium groups: p = 0.002, p = 0.007 and p < 0.0001 respectively), and between the sotalol + magnesium group and single drug groups (sotalol and magnesium groups: p = 0.04 and p = 0.01, respectively.

Conclusion: The incidence of AF after coronary surgery was significantly reduced by the administration of sotalol alone and magnesium alone. The incidence of postoperative AF was further reduced by combining the two pharmacological agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 1993;56:539–549.

    Google Scholar 

  2. Hashimoto K, Ilstrup DM, Schaff HV. Influence of clinical and hemodynamic variables on risk of supraventricular tachicardia after coronary artery bypass. J Thorac Cardiovasc Surg 1991;101:56–65.

    Google Scholar 

  3. Suttorp MJ, Kingma JH, Tjon Joe Gin RM, van Hemel NM, Koomen EM, Defauw JA, Adam AJ, Ernst SM. Efficay and safety of low-and high-dose sotalol versus propranolol in the prevention of supraventricular tachyarrhythmias early after coronary artery bypass operation. JThorac Cardiovasc Surg 1990;100:921–926.

    Google Scholar 

  4. Pfisterer ME, Kloter-Weber UC, Huber M, Osswald S, Buser PT, Skarran K, Stulz PM. Prevention of supraventricular tachyarrhythmias after open heart operation by low-dose sotalol: A prospective double blind, randomized placebo-controlled study. Ann Thorac Surg 1997;64:1113–1119.

    Google Scholar 

  5. Weber UK, Osswald S, Huber M, Buser P, Skarran K, Stulz P, Schmidhauser C, Pfisterer M. Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: Is there a need for preoperative risk stratification. Eur Heart J 1998;19:794–800.

    Google Scholar 

  6. Janssen J, Loomans L, Harink J, Taams M, Brunninkhuis L, van der Starre P, Kootstro G. Prevention and treatment of supraventricular tachycardia shortly after coronary bypass grafting: A randomized open trial. Angiology 1986;37:601–609.

    Google Scholar 

  7. Kalman JM, Munhawar M, Howes LG, Louis WJ, Buxton BF, Gutteridge G, Tonkin AM. Atrial fibrillation after coronary bypass grafting is associated with sympathetic activation. Ann Thorac Surg 1995;60:1709–1715.

    Google Scholar 

  8. Nystrom UJ, Edvardsson N, Berggren H, Pizzorelli GP, Radegran K. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgey. J Thorac Cardiovasc Surg 1993;41:34–37.

    Google Scholar 

  9. Gomez JA, Ip J, Santoni-Rugiu F. Oral d, l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: A randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 1999;34:334–339.

    Google Scholar 

  10. Daoud EG, Strickberger SA, Man KC, Goyal R, Deeb GM, Bolling SF, Pagani FD, Bitar C, Meissner MD, Moraday F. Preoperative Amiodarone as prophylaxis against atrial fibrillation after heart surgery. NEngl JMed 1997;337:1785–1791.

    Google Scholar 

  11. Parikka H, Toivonen L, Heikkila L, Virtanen K, Jarvinen A. Comparison of sotalol and metoprolol in the prevention of atrial fibrillation after coronary artery bypass surgery. J Cardiovasc Pharmachol 1998;31:67–73.

    Google Scholar 

  12. Stenley TO, Mackensen GB, Grocott HP, White WD, Blumenthal JA, Laskowitz DT, Landolfo KP, Reves JG, Mathew JP, Newman MF. The impact of postoperative atrial fibrillation on neurocognitive outcome after coronary artery bypass graft surgery. Anesth Analg 2002;94(2):290–295.

    Google Scholar 

  13. Shin H, Hashizume K, Iino Y, Koizumi K, Matayoshi, Yozu Ryohei. Effects of atrial fibrillation on coronary artery bypass graft flow. Eur J Cardiothorac Surg 2003;23:175–178.

    Google Scholar 

  14. Evrard P, Gonzalez M, Jamart J, Malhomme B, Blommaert D, Eucher P, Installe E. Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low-dose sotalol. Ann Thorac Surg 2000;70:151–156.

    Google Scholar 

  15. Taylor GJ, Mikell FL, Moses HW, Dore JT, Katholi RE, Malik SA, Markwell SJ, Korsmeyer C, Schneider JA, Wellons HA. Determinants of hospital charges for coronary artery bypass surgery: The economic consequences of postoperative complications. Am J Cardiol 1990;65:309–313.

    Google Scholar 

  16. Taylor GJ, Malik SA, Colliver, Doliver JT, Moses HW, Mikell FL, Botchelder JE, Schneider JA, Wellons HA. Usefulness of atrial fibrillation as a predictor of stroke after isolated coronary artery bypass grafting. Am J Cardiol 1987;60:905–907.

    Google Scholar 

  17. Hogue CW, Hyder ML. Atrial fibrillation after cardiac operation: Risks, mechanism, and treatment. Ann Thorac Surg 2000;69:300–306.

    Google Scholar 

  18. Katholi RE, Taylor GJ, Woods WT, Womack KA, Mikell FL, Moses HW, Dove JT, Woodruff RC, Miller BD, Song A, Wellons HA, Hamm DP, Schneider JA. Magnesium chloride replacement after bypass surgery to prevent atrial fibrillation: A double blind, randomized trial (abstract). Circulation 1995: 82 (suppl III):58.

    Google Scholar 

  19. Karmy-Jones R, Hamilton A, Dzavik V, Allegreto M, Finegan BA, Koshal A. Megnesium solfate prophylaxis after cardiac operations. Ann Thorac Surg 1995;59:502–507.

    Google Scholar 

  20. England MR, Gordon G, Salem M, Chernow B. Magnesium administration and dysrhythmias after cardiac surgery. A placebo-controlled, double-blind, randomized trial. J Am Med Assoc 1992;268:2395–2402.

    Google Scholar 

  21. Fanning WJ, Thomas CS Jr, Roach A, Tomichek R, Alford WC, Stoney WS Jr. Prophylaxis of atrial fibrillation with magnesium sulfate after coronary artery bypass grafting. Ann Thorac Surg 1991;52:529–533.

    Google Scholar 

  22. Parikka H, Toivonen L, Pellinen T, Verkkala K, Jarvinen A, Nieminen MS. The influence of intravenous magnesium sulfate on the occurrence of atrial fibrillation after coronary artery bypass operation. Eur Heart J 1993;14:251–258.

    Google Scholar 

  23. Toraman F, Karabulut H, Cem Alhan H, Dagdelen S, Tarcan S. Magnesium infusion dramatically decreases the incidence of atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2001;72:1256–1262.

    Google Scholar 

  24. Hohnloser SH, Raymold LW. Sotalol. N Eng J Med 1994;331:31–38.

    Google Scholar 

  25. Marcus FI. Risk of initiating therapy with sotalol for treatment of atrial fibrillation. J AmColl Cardiol 1998;32:177–180.

    Google Scholar 

  26. Pacifico A, Hohnloser SH, Williams JH, Tao B, Saksena S, Henry PD, Pystowsky EN. Prevention of implantabledefibrillator shocks by treatment with sotalol. NEng JMed 1999;340:1855–1862.

    Google Scholar 

  27. Zaman AG, Alamgir F, Richens T, Williams R, Rothman MT, Mills PG. The role of signal averaged P wave duration and serum magnesium as a combined predictor of atrial fibrillation after elective coronary artery bypass surgery. Heart 1997;77:527–531.

    Google Scholar 

  28. Kaplan M, Sinan Kut M, Akif Icer U, Murat Demirtas M. Intravenous magnesium sulfate prophylaxis for atrial fibrillation after coronary artery bypass surgery. J Thorac Cardiovasc Surg 2003;125:344–352.

    Google Scholar 

  29. Iseri LT, Allen BJ, Ginkel ML, Brodsky MA. Ionic biology and ionic medicine in cardiac arrhythmias with particular reference to magnesium. Am Heart J 1992;123:1404–1409.

    Google Scholar 

  30. Solomon AJ, Berger AK, Trivedi KK, Hannan RL, Katz NM. The combination of propranolol and magnesium does not prevent postoperative atrial fibrillation. Ann Thorac Surg 2000;69:126–129.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cattedra di Cardiochirurgia, University of Rome Tor Vergata, Rome, Italy

    Stefano Forlani, Marco Moscarelli, Antonio Scafuri, Antonio Pellegrino & Luigi Chiariello

Authors
  1. Stefano Forlani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marco Moscarelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antonio Scafuri
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Antonio Pellegrino
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Luigi Chiariello
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Forlani, S., Moscarelli, M., Scafuri, A. et al. Combination Therapy for Prevention of Atrial Fibrillation after Coronary Artery Bypass Surgery: A Randomized Trial of Sotalol and Magnesium. Card Electrophysiol Rev 7, 168–171 (2003). https://doi.org/10.1023/A:1027423802701

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1027423802701

Search

Navigation